Ocena wpływu erytropoetyny na jakość i czas przeżycia chorych na zaawansowanego niedrobnokomórkowego raka płuc

Od 01.2002 r. do 12.2003 r. w Klinice Chemioterapii Centrum Onkologii, Oddziału w Krakowie, przeprowadzono badanie kliniczne, dotyczące wpływu leczenia wspomagającego erytropoetyną chorych na zaawansowanego niedrobnoko...

Treatment of bone metastases in breast cancer patients

Bone metastases are a major problem in the clinical management of patients with breast cancer. With prolongation of survival, the challenge is to improve the quality of the patient’s remaining life. The treatment of me...

List do redakcji Współczesnej Onkologii

Short interfering RNA in cancer therapy

Despite modern application of surgical treatment as well as radio- and chemotherapy the results of cancer treatment are still disappointing. Genetic engineering brings new hopes and capability of interference in the gen...

Importance of soluble cytokine receptors for inflammation associated cancer

Cytokine receptors, which exist in membrane-bound and soluble form, bind their ligands with comparable affinity. While most soluble receptors are antagonists in that they compete for the ligands with their membrane count...